Biogen CEO to step down; drugmaker pulls back on Alzheimer’s drug Aduhelm
Biogen said on Tuesday (May 3) that Chief Executive Michel Vounatsos will step down and that the company is pulling back on selling its Alzheimer's drug Aduhelm after the US government's Medicare program restricted coverage of the…